# Digoxin After Acute Heart Failure

> **NCT07321509** · PHASE4 · RECRUITING · sponsor: **Guillermo Liniado** · enrollment: 120 (estimated)

## Conditions studied

- Acute Heart Failure (AHF)

## Interventions

- **OTHER:** Usual Care
- **DRUG:** Digoxin

## Key facts

- **NCT ID:** NCT07321509
- **Lead sponsor:** Guillermo Liniado
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-16
- **Primary completion:** 2027-12-16
- **Final completion:** 2028-12-16
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07321509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07321509, "Digoxin After Acute Heart Failure". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07321509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*